Calcifediol: all 26 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric ParticipantsRecruitingNCT07494045Phase 2
- REstoration of VItamin D in Pulmonary Arterial HypertensionNot yet recruitingNCT06258850Phase 4
- Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary HyperparathyroidismTerminatedNCT05543928Phase 3Results posted
- Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19CompletedNCT04551911Phase 2Results posted
- Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDITerminatedNCT03602261Phase 2Results posted
- Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D InsufficiencyCompletedNCT03588884Phase 4Results posted
- Activated Vitamin D for the Prevention and Treatment of Acute Kidney InjuryCompletedNCT02962102Phase 2Results posted
- Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)CompletedNCT02805907Phase 4Results posted
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01704079Phase 3Results posted
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01651000Phase 3Results posted
- Investigating the Effects of Hydroxyvitamin D3 on Multiple SclerosisStatus unknownNCT05340985Phase 4
- Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D DeficiencyCompletedNCT04735926Phase 2/3
- Oral 25-hydroxyvitamin D3 and COVID-19Status unknownNCT04386850Phase 2/3
- Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy SubjectsCompletedNCT03660800Phase 1
- Vitamin D Supplementation on in Major Orthopedic SurgeryCompletedNCT03403933Phase 4
- The Effect of Supplementation of Vitamin D Deficiency in Older People With Acute Hip Fracture:CompletedNCT03213886Phase 4
- Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)CompletedNCT02548364Phase 3
- Effect of vitaminD3 or 25(OH)D3 Fortified Dairy on Vitmain D Status and CVD Risk MarkersStatus unknownNCT02535910Not applicable
- To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With OsteopeniaCompletedNCT02527668Phase 2
- The Effect of Calcifediol (Hy.D 25 SD/S) and Vitamin D3 on Muscle Strength in a Frail Elderly PopulationCompletedNCT02349282Not applicable
- Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidCompletedNCT02274623Phase 1
- Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune FunctionCompletedNCT02091219Early Phase 1
- Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin DStatus unknownNCT01442272Phase 4
- Dietary Supplementation With 25-hydroxyvitamin D3 in Older AdultsCompletedNCT01398202Not applicable
- Zurich Disability Prevention TrialCompletedNCT01017354Phase 2
- Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease SubjectsCompletedNCT00888069Phase 1